index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Multi exon skipping Cells Delivery Duchenne DMD dystrophy Inbred C57BL Energy Metabolism/drug effects Long QT Dystrophie Musculaire de Becker BMD Epigenetics Muscle Biology MiARN Long noncoding RNA Gene modifiers Mice Cardiomyopathy CD38 Gene Expression Regulation/drug effects Diseases Calcium Metabolism Duchenne muscular dystrophy DMD Genomic Multi resolution modeling MES Duchenne muscular dystrophy DMO Cardiomyopathie Autophagy Immunoglobulin Fc Fragments/pharmacology Muscle Human Umbilical Vein Endothelial Cells Antisense oligonucleotides Hepatocellular carcinoma Clinical trials L-Type NNOS LncRNA CaVβs Cell Line Becker muscular dystrophy Dystrophie Musculaire de Duchenne DMD Centronuclear myopathy Modificateurs de gènes Becker BMD muscular dystrophy Gene expression Calcium Channels Exon skipping Male Muscular Atrophy Dystrophine Mitochondrial fission Muscular Dystrophy Cell homeostasis Muscle development Becker muscular dystrophy BMD Dystrophy Génomique Cachexia Hear Inhibitors Myotendinous junction Cultured DMD Cell Biology Invivo Animals Dystrophie musculaire de Becker DHPR α1S Dystrophin Multiresolution modeling LncARN BMD Dystrophin-EGFP Humans Animal/physiopathology Homeostasis Myogenesis Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Ex-vivo LKB1 Molecular docking CTNNB1 CaV subunits Skeletal muscle Molecular Sequence Data NAD+ Dynamin 2 Activin Receptors Base Sequence Dystrophin central domain Morphogenesis Knockout Drp1 Allele‐specific silencing therapy Muscular dystrophy Liver Muscles/physiopathology Muscle Strength Mdx mouse Inbred mdx